{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:54:09Z","timestamp":1788324849682,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the project of Science and Technology Plan of Liaoning Province","award":["[2022JH2\/101500016]"],"award-info":[{"award-number":["[2022JH2\/101500016]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The signal pathways mediated by axon guiding molecule netrin-1 (NTN1) are transduced via its several membrane-bound receptors that include deleted in colorectal cancer (DCC), UNC5 (A\u2013D), neogenin 1 (Neo1), melanoma cell adhesion molecule (MCAM), and Down syndrome cell adhesion molecule (DSCAM). Most of these genes play a role in the occurrence and progression of some solid tumors. Sufficient systematic studies have not been performed on the expression characteristics of the role of NTN1 and its receptors in the context of pan-cancer. Based on data from 10,437 subjects with 33 types of solid tumors in The Cancer Genome Atlas, we systematically analyzed the tumor molecular biological characteristics of NTN1 and its receptors through bioinformatics. Candidate small-molecule drugs were identified based on molecular docking analysis. Netrin-1 and its receptors exhibited stereotypical genetic alterations in tumor-suppressor genes or oncogenes. Promoter methylation and miRNA-mediated post-transcriptional inhibition likely represent the primary regulatory mechanisms, whereas the promotion of epithelial-mesenchymal transition (EMT) emerges as a conserved cellular function. we predicted potential small-molecule drugs that could bind to Netrin1 receptors. NTN1 and its receptors can be used as potential targets for tumor immunotherapy. Our results showed the important cancer biological functions of NTN1 and its receptors and their transformational value as candidate tumor biomarkers. This study also showed some critical potential immune-related therapeutic targets and provided a basis for future studies on their role in clinical immunotherapy.<\/jats:p>","DOI":"10.1038\/s41598-025-28437-0","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:26:19Z","timestamp":1765967179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pan-cancer analysis reveals netrin-1 receptors as potential tumor biomarkers and immune-related therapeutic targets"],"prefix":"10.1038","volume":"15","author":[{"given":"Ying","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"2","key":"28437_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jjcc.2013.10.006","volume":"63","author":"JB Bongo","year":"2014","unstructured":"Bongo, J. B. & Peng, D. Q. The neuroimmune guidance cue netrin-1: a new therapeutic target in cardiovascular disease. J. Cardiol. 63 (2), 95\u201398 (2014).","journal-title":"J. Cardiol."},{"issue":"4","key":"28437_CR2","doi-asserted-by":"publisher","first-page":"101042831769838","DOI":"10.1177\/1010428317698388","volume":"39","author":"U Kefeli","year":"2017","unstructured":"Kefeli, U. et al. Netrin-1 in cancer: potential biomarker and therapeutic target? Tumour Biol. 39 (4), 1010428317698388 (2017).","journal-title":"Tumour Biol."},{"issue":"3","key":"28437_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pbiomolbio.2015.04.001","volume":"118","author":"L Finci","year":"2015","unstructured":"Finci, L., Zhang, Y., Meijers, R. & Wang, J. H. Signaling mechanism of the netrin-1 receptor DCC in axon guidance. Prog Biophys. Mol. Biol. 118 (3), 153\u2013160 (2015).","journal-title":"Prog Biophys. Mol. Biol."},{"issue":"1","key":"28437_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/humu.23361","volume":"39","author":"APL Marsh","year":"2018","unstructured":"Marsh, A. P. L. et al. DCC mutation update: congenital mirror movements, isolated agenesis of the corpus callosum, and developmental split brain syndrome. Hum. Mutat. 39 (1), 23\u201339 (2018).","journal-title":"Hum. Mutat."},{"issue":"13","key":"28437_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/onc.2010.13","volume":"29","author":"D Goldschneider","year":"2010","unstructured":"Goldschneider, D. & Mehlen, P. Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29 (13), 1865\u20131882 (2010).","journal-title":"Oncogene"},{"key":"28437_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12935-023-03053-y","volume":"23","author":"X Li","year":"2023","unstructured":"Li, X. et al. UNC5D methylation mediates EMT activation via DAPK1\/AKT pathway in renal clear cell carcinoma. Cancer Cell. Int. 23, 205 (2023).","journal-title":"Cancer Cell. Int."},{"issue":"9","key":"28437_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.molmed.2012.07.001","volume":"18","author":"SY Ko","year":"2012","unstructured":"Ko, S. Y., Dass, C. R. & Nurgali, K. Netrin-1 in the developing enteric nervous system and colorectal cancer. Trends Mol. Med. 18 (9), 544\u2013554 (2012).","journal-title":"Trends Mol. Med."},{"issue":"11","key":"28437_CR8","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1136\/gutjnl-2013-306704","volume":"63","author":"P Mehlen","year":"2014","unstructured":"Mehlen, P. & Tauszig-Delamasure, S. Dependence receptors and colorectal cancer. Gut 63 (11), 1821\u20131829 (2014).","journal-title":"Gut"},{"key":"28437_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12935-020-01604-1","volume":"20","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer. Cancer Cell. Int. 20, 510 (2020).","journal-title":"Cancer Cell. Int."},{"issue":"11","key":"28437_CR10","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1242\/dev.044529","volume":"138","author":"K Lai Wing Sun","year":"2011","unstructured":"Lai Wing Sun, K., Correia, J. P. & Kennedy, T. E. Netrins: versatile extracellular cues with diverse functions. Development 138 (11), 2153\u20132169 (2011).","journal-title":"Development"},{"issue":"4","key":"28437_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1159\/000492255","volume":"48","author":"H Qu","year":"2018","unstructured":"Qu, H., Sun, H. & Wang, X. Neogenin-1 promotes cell Proliferation, Motility, and adhesion by Up-Regulation of zinc finger E-Box binding homeobox 1 via activating the Rac1\/PI3K\/AKT pathway in gastric cancer cells. Cell. Physiol. Biochem. 48 (4), 1457\u20131467 (2018).","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"28437_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cell.2008.05.030","volume":"133","author":"A Ly","year":"2008","unstructured":"Ly, A. et al. DSCAM is a Netrin receptor that collaborates with DCC in mediating turning responses to Netrin-1. Cell 133 (7), 1241\u20131254 (2008).","journal-title":"Cell"},{"issue":"3","key":"28437_CR13","first-page":"841","volume":"47","author":"JM Lehmann","year":"1987","unstructured":"Lehmann, J. M. et al. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res. 47 (3), 841\u2013845 (1987).","journal-title":"Cancer Res."},{"issue":"D1","key":"28437_CR14","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"UniProt","year":"2019","unstructured":"UniProt. A worldwide hub of protein knowledge. Nucleic Acids Res. 47 (D1), D506\u2013d15 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"28437_CR15","first-page":"D204","volume":"43","author":"UniProt","year":"2015","unstructured":"UniProt. A hub for protein information. Nucleic Acids Res. 43 (Database issue), D204\u2013D212 (2015).","journal-title":"Nucleic Acids Res."},{"key":"28437_CR16","doi-asserted-by":"crossref","unstructured":"Dun, X. P. & Parkinson, D. B. Role of Netrin-1 signaling in nerve regeneration. Int. J. Mol. Sci. ;18, 3  (2017).","DOI":"10.3390\/ijms18030491"},{"issue":"6189","key":"28437_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1126\/science.1255149","volume":"344","author":"K Xu","year":"2014","unstructured":"Xu, K. et al. Neural migration. Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism. Science 344 (6189), 1275\u20131279 (2014).","journal-title":"Science"},{"issue":"4","key":"28437_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuron.2014.07.010","volume":"83","author":"LI Finci","year":"2014","unstructured":"Finci, L. I. et al. The crystal structure of netrin-1 in complex with DCC reveals the bifunctionality of netrin-1 as a guidance cue. Neuron 83 (4), 839\u2013849 (2014).","journal-title":"Neuron"},{"issue":"2","key":"28437_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ccell.2016.01.001","volume":"29","author":"M Grandin","year":"2016","unstructured":"Grandin, M. et al. Structural decoding of the Netrin-1\/UNC5 interaction and its therapeutical implications in cancers. Cancer Cell. 29 (2), 173\u2013185 (2016).","journal-title":"Cancer Cell."},{"issue":"269","key":"28437_CR20","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6 (269), pl1 (2013).","journal-title":"Sci. Signal."},{"issue":"5","key":"28437_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2 (5), 401\u2013404 (2012).","journal-title":"Cancer Discov"},{"issue":"21","key":"28437_CR22","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu, C. J. et al. GSCALite: a web server for gene set cancer analysis. Bioinformatics 34 (21), 3771\u20133772 (2018).","journal-title":"Bioinformatics"},{"issue":"1","key":"28437_CR23","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41598-020-62117-5","volume":"10","author":"W Hao","year":"2020","unstructured":"Hao, W. et al. The pan-cancer landscape of Netrin family reveals potential oncogenic biomarkers. Sci. Rep. 10 (1), 5224 (2020).","journal-title":"Sci. Rep."},{"issue":"W1","key":"28437_CR24","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46 (W1), W296\u2013w303 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"28437_CR25","doi-asserted-by":"publisher","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","volume":"45","author":"S Bienert","year":"2017","unstructured":"Bienert, S. et al. The SWISS-MODEL Repository-new features and functionality. Nucleic Acids Res. 45 (D1), D313\u2013d9 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"28437_CR26","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1038\/s41598-017-09654-8","volume":"7","author":"M Bertoni","year":"2017","unstructured":"Bertoni, M., Kiefer, F., Biasini, M., Bordoli, L. & Schwede, T. Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology. Sci. Rep. 7 (1), 10480 (2017).","journal-title":"Sci. Rep."},{"issue":"D1","key":"28437_CR27","doi-asserted-by":"publisher","first-page":"D298","DOI":"10.1093\/nar\/gky1074","volume":"47","author":"KY Huang","year":"2019","unstructured":"Huang, K. Y. et al. DbPTM in 2019: exploring disease association and cross-talk of post-translational modifications. Nucleic Acids Res. 47 (D1), D298\u2013d308 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"28437_CR28","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkx1018","volume":"46","author":"X Hu","year":"2018","unstructured":"Hu, X. et al. TumorFusions: an integrative resource for cancer-associated transcript fusions. Nucleic Acids Res. 46 (D1), D1144\u2013d9 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"28437_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<716::AID-IJC14>3.0.CO;2-7","volume":"70","author":"M Okamoto","year":"1997","unstructured":"Okamoto, M., Reddy, J. K. & Oyasu, R. Tumorigenic conversion of a non-tumorigenic rat urothelial cell line by overexpression of H2O2-generating peroxisomal fatty acyl-CoA oxidase. Int. J. Cancer. 70 (6), 716\u2013721 (1997).","journal-title":"Int. J. Cancer"},{"issue":"2","key":"28437_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.juro.2014.01.108","volume":"192","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y. et al. Down-regulation of UNC5D in bladder cancer: UNC5D as a possible mediator of cisplatin induced apoptosis in bladder cancer cells. J. Urol. 192 (2), 575\u2013582 (2014).","journal-title":"J. Urol."},{"issue":"D1","key":"28437_CR31","first-page":"D682","volume":"48","author":"AD Yates","year":"2020","unstructured":"Yates, A. D. et al. Ensembl 2020. Nucleic Acids Res. 48 (D1), D682\u2013d8 (2020).","journal-title":"Nucleic Acids Res."},{"key":"28437_CR32","unstructured":"Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. ;46 (D1), D8\u2013d13  (2018)."},{"issue":"1","key":"28437_CR33","first-page":"244","volume":"8","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma. Int. J. Clin. Exp. Pathol. 8 (1), 244\u2013251 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"28437_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1724600819898489","volume":"35","author":"F Liu","year":"2020","unstructured":"Liu, F., Xiao, Y., Ma, L. & Wang, J. Regulating of cell cycle progression by the LncRNA CDKN2B-AS1\/miR-324-5p\/ROCK1 axis in laryngeal squamous cell cancer. Int. J. Biol. Markers. 35 (1), 47\u201356 (2020).","journal-title":"Int. J. Biol. Markers"},{"issue":"18","key":"28437_CR35","doi-asserted-by":"publisher","first-page":"26087","DOI":"10.18632\/oncotarget.8317","volume":"7","author":"K Misawa","year":"2016","unstructured":"Misawa, K. et al. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer. Oncotarget 7 (18), 26087\u201326098 (2016).","journal-title":"Oncotarget"},{"issue":"5","key":"28437_CR36","doi-asserted-by":"publisher","first-page":"e0126128","DOI":"10.1371\/journal.pone.0126128","volume":"10","author":"H Wu","year":"2015","unstructured":"Wu, H. et al. Ano1\/TMEM16A overexpression is associated with good prognosis in PR-Positive or HER2-Negative breast cancer patients following Tamoxifen treatment. PLoS One. 10 (5), e0126128 (2015).","journal-title":"PLoS One"},{"issue":"D1","key":"28437_CR37","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar, S. V., Straub, P., Wang, J. & Zhang, B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 46 (D1), D956\u2013d63 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"28437_CR38","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45 (W1), W98\u2013w102 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"28437_CR39","first-page":"3501","volume":"18","author":"B Jia","year":"2019","unstructured":"Jia, B. et al. Prognostic roles of MAGE family members in breast cancer based on KM-Plotter data. Oncol. Lett. 18 (4), 3501\u20133516 (2019).","journal-title":"Oncol. Lett."},{"issue":"11","key":"28437_CR40","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1158\/1078-0432.CCR-12-2978","volume":"19","author":"D Lu","year":"2013","unstructured":"Lu, D. et al. The tumor-suppressive function of UNC5D and its repressed expression in renal cell carcinoma. Clin. Cancer Res. 19 (11), 2883\u20132892 (2013).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"28437_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13072-019-0316-3","volume":"12","author":"Y Li","year":"2019","unstructured":"Li, Y., Ge, D. & Lu, C. The SMART app: an interactive web application for comprehensive DNA methylation analysis and visualization. Epigenetics Chromatin. 12 (1), 71 (2019).","journal-title":"Epigenetics Chromatin"},{"issue":"D1","key":"28437_CR42","doi-asserted-by":"publisher","first-page":"D43","DOI":"10.1093\/nar\/gkw965","volume":"45","author":"KR Zhou","year":"2017","unstructured":"Zhou, K. R. et al. ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucleic Acids Res. 45 (D1), D43\u2013d50 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"28","key":"28437_CR43","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1038\/onc.2017.50","volume":"36","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. FOXA1 inhibits prostate cancer neuroendocrine differentiation. Oncogene 36 (28), 4072\u20134080 (2017).","journal-title":"Oncogene"},{"issue":"3","key":"28437_CR44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ijc.10821","volume":"103","author":"A Latil","year":"2003","unstructured":"Latil, A. et al. Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int. J. Cancer. 103 (3), 306\u2013315 (2003).","journal-title":"Int. J. Cancer"},{"issue":"5","key":"28437_CR45","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s13277-013-0834-8","volume":"34","author":"CZ Kong","year":"2013","unstructured":"Kong, C. Z., Liu, J., Liu, L., Zhang, Z. & Guo, K. F. Interactional expression of netrin-1 and its dependence receptor UNC5B in prostate carcinoma. Tumour Biol. 34 (5), 2765\u20132772 (2013).","journal-title":"Tumour Biol."},{"issue":"3","key":"28437_CR46","first-page":"456","volume":"13","author":"L Zhai","year":"2020","unstructured":"Zhai, L. et al. Expression of EZH2 and P53 and their correlation in ovarian cancer tissues. Int. J. Clin. Exp. Pathol. 13 (3), 456\u2013464 (2020).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"28437_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/CCO.0000000000000390","volume":"29","author":"M Yamagishi","year":"2017","unstructured":"Yamagishi, M. & Uchimaru, K. Targeting EZH2 in cancer therapy. Curr. Opin. Oncol. 29 (5), 375\u2013381 (2017).","journal-title":"Curr. Opin. Oncol."},{"key":"28437_CR48","doi-asserted-by":"crossref","unstructured":"Abdel Raouf, S. M., Ibrahim, T. R., Abdelaziz, L. A., Farid, M. I. & Mohamed, S. Y. Prognostic value of TWIST1 and EZH2 expression in colon cancer. J. Gastrointest. Cancer (2019).","DOI":"10.1007\/s12029-019-00344-4"},{"issue":"2","key":"28437_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1381612823666171114165051","volume":"24","author":"SS Soflaei","year":"2018","unstructured":"Soflaei, S. S. et al. Curcumin: A natural Pan-HDAC inhibitor in cancer. Curr. Pharm. Des. 24 (2), 123\u2013129 (2018).","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"28437_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4068\/cmj.2016.52.1.1","volume":"52","author":"S Yoon","year":"2016","unstructured":"Yoon, S. & Eom, G. H. HDAC and HDAC inhibitor: from cancer to cardiovascular diseases. Chonnam Med. J. 52 (1), 1\u201311 (2016).","journal-title":"Chonnam Med. J."},{"issue":"7","key":"28437_CR51","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00204-018-2229-5","volume":"92","author":"N Kiweler","year":"2018","unstructured":"Kiweler, N. et al. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch. Toxicol. 92 (7), 2227\u20132243 (2018).","journal-title":"Arch. Toxicol."},{"key":"28437_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/1471-2407-8-381","volume":"8","author":"FR Fritzsche","year":"2008","unstructured":"Fritzsche, F. R. et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer. 8, 381 (2008).","journal-title":"BMC Cancer"},{"issue":"25","key":"28437_CR53","doi-asserted-by":"publisher","first-page":"40583","DOI":"10.18632\/oncotarget.17196","volume":"8","author":"S Dong","year":"2017","unstructured":"Dong, S. et al. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor. Oncotarget 8 (25), 40583\u201340593 (2017).","journal-title":"Oncotarget"},{"issue":"3","key":"28437_CR54","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12253-012-9499-7","volume":"18","author":"JS Jin","year":"2012","unstructured":"Jin, J. S., Tsao, T. Y., Sun, P. C., Yu, C. P. & Tzao, C. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of Cyclin D1 and survivin. Pathol. Oncol. Res. 18 (3), 713\u2013720 (2012).","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"28437_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40291-020-00454-x","volume":"24","author":"A Mastoraki","year":"2020","unstructured":"Mastoraki, A. et al. Contribution of histone deacetylases in prognosis and therapeutic management of cholangiocarcinoma. Mol. Diagn. Ther. 24 (2), 175\u2013184 (2020).","journal-title":"Mol. Diagn. Ther."},{"issue":"10","key":"28437_CR56","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht, C., De La Torre, C., Parveen, A. & Gretz, N. MiRWalk: an online resource for prediction of MicroRNA binding sites. PLoS One. 13 (10), e0206239 (2018).","journal-title":"PLoS One"},{"issue":"Database issue","key":"28437_CR57","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. StarBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42 (Database issue), D92\u2013D97 (2014).","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"28437_CR58","doi-asserted-by":"publisher","first-page":"D1348","DOI":"10.1093\/nar\/gkab1084","volume":"50","author":"N Feizi","year":"2022","unstructured":"Feizi, N. et al. PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis. Nucleic Acids Res. 50 (Database issue), D1348\u2013D1349 (2022).","journal-title":"Nucleic Acids Res."},{"key":"28437_CR59","doi-asserted-by":"crossref","unstructured":"Huang, C. Y. et al. Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line chemotherapy for patients with FIGO IIIC Serous-Type Tubo-Ovarian cancer. Int. J. Environ. Res. Public. Health ;17, 7 (2020).","DOI":"10.3390\/ijerph17072213"},{"issue":"11","key":"28437_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1556\/650.2020.31614","volume":"161","author":"J Kalincs\u00e1k","year":"2020","unstructured":"Kalincs\u00e1k, J. et al. [Preoperative systemic treatment of locally and locoregionally advanced high-risk endometrial cancer]. Orv Hetil. 161 (11), 425\u2013433 (2020).","journal-title":"Orv Hetil"},{"issue":"1","key":"28437_CR61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12885-019-5335-8","volume":"19","author":"A Petitjean","year":"2019","unstructured":"Petitjean, A., Smith-Palmer, J., Valentine, W., Tehard, B. & Roze, S. Cost-effectiveness of bevacizumab plus Paclitaxel versus Paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France. BMC Cancer. 19 (1), 140 (2019).","journal-title":"BMC Cancer"},{"key":"28437_CR62","doi-asserted-by":"crossref","unstructured":"Hamilton, N. et al. Receptors for Insulin-Like growth Factor-2 and androgens as therapeutic targets in Triple-Negative breast cancer. Int. J. Mol. Sci. 18, 11 (2017).","DOI":"10.3390\/ijms18112305"},{"issue":"6","key":"28437_CR63","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12282-019-00973-4","volume":"26","author":"JFR Robertson","year":"2019","unstructured":"Robertson, J. F. R. et al. A meta-analysis of clinical benefit rates for fulvestrant 500\u00a0mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer. Breast Cancer. 26 (6), 703\u2013711 (2019).","journal-title":"Breast Cancer"},{"issue":"6","key":"28437_CR64","first-page":"5023","volume":"19","author":"DM Rodrigues-Junior","year":"2019","unstructured":"Rodrigues-Junior, D. M. et al. Downregulation of DCC sensitizes multiple myeloma cells to bortezomib treatment. Mol. Med. Rep. 19 (6), 5023\u20135029 (2019).","journal-title":"Mol. Med. Rep."},{"key":"28437_CR65","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fonc.2018.00092","volume":"8","author":"A Suraweera","year":"2018","unstructured":"Suraweera, A., O\u2019Byrne, K. J. & Richard, D. J. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi. Front. Oncol. 8, 92 (2018).","journal-title":"Front. Oncol."},{"issue":"20","key":"28437_CR66","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1158\/1078-0432.CCR-22-2867","volume":"28","author":"X Ma","year":"2022","unstructured":"Ma, X. et al. Correction: Synergistic killing effect between Vorinostat and target of CD146 in malignant cells. Clin. Cancer Res. 28 (20), 4589 (2022).","journal-title":"Clin. Cancer Res."},{"key":"28437_CR67","unstructured":"Mao, X. et al. Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer. Am. J. Cancer Res., 1, 5  (2011)."},{"issue":"8","key":"28437_CR68","doi-asserted-by":"publisher","first-page":"e0160685","DOI":"10.1371\/journal.pone.0160685","volume":"11","author":"L Taylor","year":"2016","unstructured":"Taylor, L., Brodermann, M. H., Mccaffary, D., Iqbal, A. J. & Greaves, D. R. Netrin-1 reduces monocyte and macrophage chemotaxis towards the complement component c5a. PLoS ONE. 11 (8), e0160685 (2016).","journal-title":"PLoS ONE"},{"issue":"4","key":"28437_CR69","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.4049\/jimmunol.1502432","volume":"197","author":"L Boneschansker","year":"2016","unstructured":"Boneschansker, L. et al. Netrin-1 augments chemokinesis in cd4\u2009+\u2009t cells in vitro and elicits a Proinflammatory response in vivo. J. Immunol. 197 (4), 1389\u20131398 (2016).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28437-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28437-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28437-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:01:52Z","timestamp":1765972912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28437-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28437"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28437-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is a retrospective bioinformatics analysis that exclusively uses publicly available omics data and does not involve human subjects, human tissues, or animal experiments. All data utilized in this research were obtained from open-access databases, and the study strictly adheres to the data usage guidelines of each database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval"}}],"article-number":"44015"}}